Reference: Ref-18649
| Reference Name: | CF-MH 3042a General Authorization for Treatment Except Psychotropic Medications |
| Agency: | 65 Department of Children and Families 65E Mental Health Program |
| Modified Document(s): |
|
|||||
|---|---|---|---|---|---|---|
| Adopted Document(s): |
|
|||||
| Proposed Document(s): |
|
|||||
| Description: | ||||||
Disclaimer: External links within the reference material are subject to change outside of the rulemaking process.
Rules/Notices using this Reference Material| Notice / Adopted |
Description | ID | Publish Date |
|
|---|---|---|---|---|
|
Right to Express and Informed Consent | 30215226 |
Effective: 11/27/2025 |
|
|
|
Amendments align these Baker Act rules with recent statutory changes to Chapter 394, F.S., provide additional clarity for providers and other stakeholders, and update rules to meet current best practice guidelines. | 29977188 |
9/11/2025 Vol. 51/177 |
|